VitaSpring Biomedical Co. Ltd. (VSBC) stock
VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $6.58MP/E –Yield –
VitaSpring Biomedical gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
VitaSpring Biomedical's gross profit for the twelve months ending Jan 31, 2024 was $0. For fiscal 2026 it was $0. The highest annual figure on record is $2.07M in fiscal 2022.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $0 | – |
| FY2025 | Jan 31, 2025 | $0 | – |
| FY2024 | Jan 31, 2024 | $0 | – |
| FY2023 | Jan 31, 2023 | -$3.33M | -261.2% |
| FY2022 | Jan 31, 2022 | $2.07M | +1743.1% |
| FY2021 | Jan 31, 2021 | $112.20K | +6519.5% |
| FY2020 | Jan 31, 2020 | $1.70K | -87.6% |
| FY2019 | Jan 31, 2019 | $13.72K | +21.0% |
| FY2018 | Jan 31, 2018 | $11.34K | – |
| FY2017 | Jan 31, 2017 | $0 | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $0 | – |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $0 | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $0 | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $0 | -100.0% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$3.90M | -365.9% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $0 | -100.0% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $0 | -100.0% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $568.00K | +136.9% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $1.47M | +1207.5% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $20.00K | – |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $341.20K | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $239.80K | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $112.20K | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $0 | -100.0% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $0 | -100.0% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $0 | -100.0% |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$4.54K | -294.5% |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | $3.54K | +5428.1% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | $3.54K | +122.8% |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | $6.31K | -35.1% |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | $2.34K | +85.0% |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $64 | -97.8% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $1.59K | -18.7% |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | $9.73K | +88.9% |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | $1.26K | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | $2.97K | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | $1.95K | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | $5.15K | – |
See a number that looks wrong?